US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NVIDIA Portfolio

2,651.61

+7.890.30%

Number of Gainers:4

Number of Losers:4

Number of Flat:- -

PE:- -

High:2,705.45

Open:2,647.15

Low:2,622.36

Close:2,643.73

Loading ...

Why SoundHound AI Stock Jumped 12% on Tuesday

Recursion Pharmaceuticals call volume above normal and directionally bullish

Mixed options sentiment in Applied Digital Corp with shares down 2.38%

Unusually active option classes on open July 8th

Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement

Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program

Rallybio Corporation Divests Interest in REV102 Program to Recursion Pharmaceuticals for Up to $25 Million

Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026

Recursion Pharmaceuticals Inc - Rallybio Eligible for $7.5 Mln Upfront and $12.5 Mln Contingent

THOMSON REUTERS

Recursion Pharmaceuticals Inc - Rallybio to Receive Low Single-Digit Royalties on Future Sales

THOMSON REUTERS

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral Enpp1 Inhibitor for Hypophosphatasia

THOMSON REUTERS

Recursion Pharmaceuticals Inc - REV102 Phase 1 Clinical Trials Expected in Second Half of 2026

THOMSON REUTERS

Rallybio Corp - Expects Cash Runway Extension to Mid-2027

THOMSON REUTERS

Rallybio Corp - Sells REV102 Interest to Recursion for up to $25 Mln Including an Upfront Equity Payment of $7.5 Million

THOMSON REUTERS

Rallybio Corp - Eligible for $7.5 Mln Upfront, $12.5 Mln Contingent Equity

THOMSON REUTERS

Rallybio : Expects Its Cash Runway to Extend Into Mid-2027

THOMSON REUTERS

ARM Holdings plc to Announce Financial Results for First Quarter Fiscal Year 2026

How SoundHound AI Is Quietly Building a Global AI Empire

Nucor, Seagate, Appian, ADP, Serve Robotics: Insider Moves Unveiled

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4609/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4609","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","market":"US","secType":"PLATE","nameCN":"NVIDIA Portfolio","latestPrice":2651.614,"timestamp":1752868799999,"preClose":2643.7268,"halted":0,"volume":179694641,"delay":0,"changeRate":0.002983,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":7.887207,"latestTime":"07-18 16:00:00 EDT","open":2647.148,"high":2705.4492,"low":2622.364,"amount":2918874325.827694,"amplitude":0.031427,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":14.68613,"peRate":-176.637535,"turnoverRate":0.113797,"increases":4,"decrements":4,"flats":0,"marketCap":192332881664,"floatMarketCap":42723611008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4609\",,,,,undefined,":{"symbol":"BK4609","high":2705.4492,"amplitude":0.031427,"preClose":2643.7268,"low":2622.364,"pbRate":"14.68613","latestPrice":2651.614,"volume":179694641,"delay":0,"open":2647.148,"prevYearClose":2189.1055,"prevWeekClose":2364.5405,"prevMonthClose":2621.4265,"prevQuarterClose":2621.4265,"fiveDayClose":2364.5405,"twentyDayClose":2374.9912,"sixtyDayClose":1546.3049,"secType":"PLATE","market":"US","turnoverRate":0.113797,"peRate":-176.637535,"marketCap":192332881664,"floatMarketCap":42723611008,"timestamp":1752868799999,"nameCN":"NVIDIA Portfolio"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4609\",,,,undefined,":{"bkCode":"BK4609","up":4,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4609\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550357880","title":"Why SoundHound AI Stock Jumped 12% on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2550357880","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550357880?lang=en_us&edition=fundamental","pubTime":"2025-07-09 09:41","pubTimestamp":1752025260,"startTime":"0","endTime":"0","summary":"$SoundHound AI(SOUN)$’s stock jumped as much as 11.69% on Tuesday.Investor interest in agentic AI solutions fueled the stock’s dramatic move.SoundHound AI’s stock valuation remains high despite the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/08/why-soundhound-ai-stock-jumped-17-tuesday-morning/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Why SoundHound AI Stock Jumped 12% on Tuesday","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4609","BK4587","SOUN","BK4608","BK4023","BK4613","BK4547"],"gpt_icon":0},{"id":"2550520268","title":"Recursion Pharmaceuticals call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550520268?lang=en_us&edition=fundamental","pubTime":"2025-07-09 03:05","pubTimestamp":1752001512,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 20,287 calls trading, 1.0x expected, and implied vol increasing almost 53 poi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-thefly-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-thefly-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4611","BK4548","RXRX","BK4609","BK4139"],"gpt_icon":0},{"id":"2550652445","title":"Mixed options sentiment in Applied Digital Corp with shares down 2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550652445?lang=en_us&edition=fundamental","pubTime":"2025-07-09 00:25","pubTimestamp":1751991914,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in Applied Digital Corp (APLD), with shares down 23c near $9.43. Options volume relatively light with 35k contracts traded ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-applied-digital-corp-with-shares-down-2-38-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-applied-digital-corp-with-shares-down-2-38-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APLD","BK4608","BK4609","BK4023","BK4116"],"gpt_icon":0},{"id":"2549528451","title":"Unusually active option classes on open July 8th","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549528451?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:40","pubTimestamp":1751982027,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: ReNew Energy Global PLC (RNW), Bit Digital (BTBT), SoundHound AI (SOUN), Datadog (DDOG), Farad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-july-8th-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-july-8th-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","SOUN","LU0823414478.USD","BK4547","LU2357125470.USD","BK4535","LU2249611893.SGD","BK4600","DDOG","BK4548","BK4551","BK4587","RNW","LU1548497426.USD","BK4516","BK4588","LU2264538146.SGD","LU2357305700.SGD","BK4528","BK4595","LU1988902786.USD","LU2294711713.HKD","BK4561","BK4607","LU1064131342.USD","BK4133","BTBT","LU0823414551.USD","LU1720051017.SGD","BK4023","BK4609","LU2286300806.USD","BK4608","LU2506951792.HKD","BK4585","LU1720051108.HKD"],"gpt_icon":0},{"id":"2549540746","title":"Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549540746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549540746?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:12","pubTimestamp":1751980334,"startTime":"0","endTime":"0","summary":"Rallybio stock soared on Tuesday after the company reached an agreement with Recursion Pharmaceuticals.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/rallybio-stock-rlyb-rockets-25-on-a-recursion-pharmaceuticals-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/rallybio-stock-rlyb-rockets-25-on-a-recursion-pharmaceuticals-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RLYB","BK4548","RXRX","BK4611","BK4139","BK4539","BK4609"],"gpt_icon":0},{"id":"2549347547","title":"Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2549347547","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549347547?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:45","pubTimestamp":1751978704,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals ( ($RXRX) ) just unveiled an announcement. On July 8, 2025, Recursion Pharmaceuticals acquired full ownership of the ENPP...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-pharmaceuticals-acquires-enpp1-inhibitor-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-pharmaceuticals-acquires-enpp1-inhibitor-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4609","RXRX","BK4139","BK4539","BK4548","BK4611"],"gpt_icon":0},{"id":"2549544605","title":"Rallybio Corporation Divests Interest in REV102 Program to Recursion Pharmaceuticals for Up to $25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544605","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544605?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976038,"startTime":"0","endTime":"0","summary":"Rallybio Corporation has announced the sale of its interest in the REV102 program to Recursion Pharmaceuticals, a move anticipated to extend Rallybio's cash runway to mid-2027. The deal, valued at up to $25 million, includes an upfront equity payment of $7.5 million and additional milestone payments. The REV102 program, focused on developing an ENPP1 inhibitor for treating hypophosphatasia , originated from a joint venture between the two companies. Rallybio's CEO, Stephen Uden, expressed enthusiasm for the program's progression, highlighting the collaboration's success in advancing a potential oral disease-modifying treatment for HPP.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content us","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL1rRsmK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","RLYB","BK4609","BK4548","BK4539","BK4611","BK4139"],"gpt_icon":1},{"id":"2549645544","title":"Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2549645544","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549645544?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976034,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026. Recursion Pharmaceuticals Inc.  has announced the acquisition of Rallybio's full interest in their joint ENPP1 inhibitor program, REV102, designed for the treatment of hypophosphatasia , a rare genetic disorder. The acquisition includes an associated backup molecule. This move grants Recursion full ownership of the program, allowing the company to expedite the development of what could become the first oral disease-modifying therapy for HPP. Currently in IND-enabling studies, REV102 is expected to enter Phase 1 clinical trials in the second half of 2026. The program aims to address the underlying cause of HPP by inhibiting the enzyme ENPP1, potentially improving bone mineralization. Results of these studies have yet to be presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL5SzTHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4611","BK4588","LU2210149790.SGD","BK4585","NDAQ","BK4139","LU2210150020.SGD","BK4539","IE00BKPKM429.USD","BK4112","BK4548","BK4609","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","RLYB","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2549616544","title":"Recursion Pharmaceuticals Inc - Rallybio Eligible for $7.5 Mln Upfront and $12.5 Mln Contingent","url":"https://stock-news.laohu8.com/highlight/detail?id=2549616544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549616544?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA7XRCDR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4609","BK4139","RXRX","BK4611","BK4539"],"gpt_icon":0},{"id":"2549544692","title":"Recursion Pharmaceuticals Inc - Rallybio to Receive Low Single-Digit Royalties on Future Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544692?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA7XRCDR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BK4611","BK4609","RXRX","BK4548"],"gpt_icon":0},{"id":"2549544321","title":"Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral Enpp1 Inhibitor for Hypophosphatasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544321?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA7XRCDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","RXRX","BK4139","BK4539","BK4611","BK4609"],"gpt_icon":0},{"id":"2549446955","title":"Recursion Pharmaceuticals Inc - REV102 Phase 1 Clinical Trials Expected in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2549446955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549446955?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA7XRCDR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4539","BK4611","BK4548","BK4609","BK4139"],"gpt_icon":0},{"id":"2549954499","title":"Rallybio Corp - Expects Cash Runway Extension to Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2549954499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549954499?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA3RGDFS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RLYB","BK4139","BK4611","BK4609","RXRX","BK4548"],"gpt_icon":0},{"id":"2549544998","title":"Rallybio Corp - Sells REV102 Interest to Recursion for up to $25 Mln Including an Upfront Equity Payment of $7.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544998?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA3RGDFS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4139","BK4611","BK4539","RXRX","RLYB","BK4548"],"gpt_icon":0},{"id":"2549544995","title":"Rallybio Corp - Eligible for $7.5 Mln Upfront, $12.5 Mln Contingent Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544995?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA3RGDFS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLYB","BK4611","BK4139","RXRX","BK4539","BK4548","BK4609"],"gpt_icon":0},{"id":"2549544960","title":"Rallybio : Expects Its Cash Runway to Extend Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544960?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA3RGDFS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RLYB","BK4139","BK4611","BK4609","RXRX","BK4548"],"gpt_icon":0},{"id":"2549453791","title":"ARM Holdings plc to Announce Financial Results for First Quarter Fiscal Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2549453791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549453791?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:00","pubTimestamp":1751893236,"startTime":"0","endTime":"0","summary":"ARM Holdings plc will report financial results for the first quarter of fiscal year 2026 on Wednesday, July 30, 2025, after market close. The results will be released via an audio webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARM Holdings plc published the original content used to generate this news brief via Business Wire  on July 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDL3lP4NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BMPRXN33.USD","LU0348723411.USD","IE00BMPRXR70.SGD","ARM","BK4141","BK4609","BK4588","IE00BMPRXQ63.HKD","BK4543"],"gpt_icon":1},{"id":"2549373119","title":"How SoundHound AI Is Quietly Building a Global AI Empire","url":"https://stock-news.laohu8.com/highlight/detail?id=2549373119","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549373119?lang=en_us&edition=fundamental","pubTime":"2025-07-07 00:10","pubTimestamp":1751818200,"startTime":"0","endTime":"0","summary":"SoundHound AI offers integrated and proprietary AI solutions for more than 25 languages.It has huge global opportunitiesin the automotiveand restaurantsectors.It is diversifyinginto other industries with different monetisation strategies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/06/how-soundhound-ai-is-quietly-building-a-global-ai/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0097036916.USD","SG9999014898.SGD","LU1935043023.USD","SOUN","LU1935043536.SGD","LU2168564065.EUR","LU0256863811.USD","LU2087625088.SGD","LU0957808578.USD","LU1670627923.USD","LU0215105999.USD","BK4592","BK4503","LU0276348264.USD","LU0820562030.AUD","LU0882574139.USD","LU0077335932.USD","LU1084165304.USD","LU2106854487.HKD","BK4576","LU1923623000.USD","SG9999014914.USD","LU2077746001.SGD","BK4609","LU2456880835.USD","IE00BQXX3C00.GBP","LU1699723380.USD","LU2265009873.SGD","IE00BWXC8680.SGD","LU0061474960.USD","SG9999015952.SGD","LU1267930730.SGD","LU1429558221.USD","LU2430703178.SGD","LU1066053197.SGD","LU0061475181.USD","LU0154236417.USD","LU1059921491.USD","LU0345769128.USD","LU0265550359.USD","IE00BMPRXR70.SGD","LU1642822529.SGD","LU2023250843.SGD","LU2404859667.USD","LU0109391861.USD","LU1043141123.HKD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU0157215616.USD"],"gpt_icon":1},{"id":"2549834603","title":"Nucor, Seagate, Appian, ADP, Serve Robotics: Insider Moves Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2549834603","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549834603?lang=en_us&edition=fundamental","pubTime":"2025-07-05 21:02","pubTimestamp":1751720549,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($NUE)), (($STX)), (($APPN)), (($ADP)) and (($SERV)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/nucor-seagate-appian-adp-serve-robotics-insider-moves-unveiled?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/nucor-seagate-appian-adp-serve-robotics-insider-moves-unveiled?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADP","BK4528","BK4613","IE00BYQQ9H92.USD","SERV","LU1023059493.AUD","LU1934455194.USD","LU0330918003.SGD","LU0965509101.SGD","LU1236620750.USD","BK4106","LU1228905037.USD","LU2506952170.USD","LU0950375773.USD","LU0690374615.EUR","LU0170899867.USD","IE00BFXG0V08.USD","LU1032955483.USD","LU0861579265.USD","LU0965509010.AUD","BK4130","LU0690374961.EUR","BK4609","GB00B4QBRK32.GBP","LU0075056555.USD","LU1228905540.USD","BK4585","LU0345774631.USD","NUE","BK4604","LU0788109121.HKD","LU0823417737.USD","LU0823417653.USD","LU2506951875.HKD","LU2506951958.HKD","LU0345774391.USD","GB00B4LPDJ14.GBP","LU0965509283.SGD","LU0289941410.SGD","LU0868494617.USD","LU1934455277.USD","LU1236620834.HKD","LU2404859741.USD","LU1221951046.USD","LU1196500208.SGD","LU2404859667.USD","LU1037948541.HKD","LU2506952097.USD","BK4209","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":79,"code":"91000000","status":"200"}]}}